ADANI, Giorgia, Tommaso FILIPPINI, Lauren A. WISE, Thorhallur I. HALLDORSSON, Luděk BLÁHA a Marco VINCETI. Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis. Cancer Epidemiology, Biomarkers & Prevention. Philadelphia: American Association for Cancer Research, 2020, roč. 29, č. 6, s. 1095-1106. ISSN 1055-9965. Dostupné z: https://dx.doi.org/10.1158/1055-9965.EPI-19-1628.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose-Response Meta-analysis
Autoři ADANI, Giorgia (380 Itálie), Tommaso FILIPPINI (380 Itálie), Lauren A. WISE (840 Spojené státy), Thorhallur I. HALLDORSSON (208 Dánsko), Luděk BLÁHA (203 Česká republika, garant, domácí) a Marco VINCETI (380 Itálie).
Vydání Cancer Epidemiology, Biomarkers & Prevention, Philadelphia, American Association for Cancer Research, 2020, 1055-9965.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30304 Public and environmental health
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.254
Kód RIV RIV/00216224:14310/20:00116472
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1158/1055-9965.EPI-19-1628
UT WoS 000539997800002
Klíčová slova anglicky NONSMOKING POSTMENOPAUSAL WOMEN; HEMOGLOBIN ADDUCT LEVELS; PROSPECTIVE COHORT; DRINKING-WATER; B6C3F(1) MICE; AIR-POLLUTION; F344/N RATS; GLYCIDAMIDE; EXPOSURE; CARCINOGENICITY
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Marie Šípková, DiS., učo 437722. Změněno: 30. 10. 2020 16:23.
Anotace
Acrylamide is a probable human carcinogen. Aside from occupational exposures and smoking, diet is the main source of exposure in humans. We performed a systematic review of the association between estimated dietary intake of acrylamide and risk of female breast, endometrial, and ovarian cancers in nonexperimental studies published through February 25, 2020, and conducted a dose-response meta-analysis. We identified 18 papers covering 10 different study populations: 16 cohort and two case-control studies. Acrylamide intake was associated with a slightly increased risk of ovarian cancer, particularly among never smokers. For endometrial cancer, risk was highest at intermediate levels of exposure, whereas the association was more linear and positive among never smokers. For breast cancer, we found evidence of a null or inverse relation between exposure and risk, particularly among never smokers and postmenopausal women. In a subgroup analysis limited to premenopausal women, breast cancer risk increased linearly with acrylamide intake starting at 20 mg/day of intake. High acrylamide intake was associated with increased risks of ovarian and endometrial cancers in a relatively linear manner, especially among never smokers. Conversely, little association was observed between acrylamide intake and breast cancer risk, with the exception of premenopausal women.
Návaznosti
733032, interní kód MUNázev: European Human Biomonitoring Initiative (Akronym: HBM4EU)
Investor: Evropská unie, European Human Biomonitoring Initiative, Health, demographic change and wellbeing (Societal Challenges)
VytisknoutZobrazeno: 11. 7. 2024 18:42